Literature DB >> 8652931

Rhabdomyolysis complicating polymicrobial sepsis in a patient with acute leukemia.

H Funada1, H Shirasaki, T Matsuda, M Akasofu.   

Abstract

Rhabdomyolysis with myoglobinuria is an uncommon complication of sepsis, whether monomicrobial or polymicrobial, even in its severe form. We describe a middle-aged woman with acute leukemia who developed rhabdomyolysis and myoglobinuria during the fatal course of chemotherapy-induced sepsis due to Bacteroides thetaiotaomicron and Enterococcus faecalis, followed by multiple organ dysfunction syndrome. In addition, autopsy revealed disseminated infections with Aspergillus and Candida. None of these organisms has been reported to be involved in the pathogenesis of rhabdomyolysis. Therefore, the etiology of the rhabdomyolysis in this case was probably multifactorial, with polymicrobial septic processes being possibly important contributing factors.

Entities:  

Mesh:

Year:  1996        PMID: 8652931     DOI: 10.2169/internalmedicine.35.36

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Peritoneal dialysis peritonitis caused by Bacteroides thetaiotaomicron.

Authors:  C M Chao; W L Liu; C C Lai
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

2.  Rhabdomyolysis during myelosuppression in a patient with central nervous system leukemia: A case report.

Authors:  Ying Le; Huiqun Li; Chengyao Wan; Yuan Long; Zhenfang Liu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

3.  Rhabdomyolysis in community acquired bacterial sepsis--a retrospective cohort study.

Authors:  Anita A Kumar; Emmanuel Bhaskar; Ghanshyam Palamaner Subash Shantha; Porchelvan Swaminathan; Georgi Abraham
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

4.  Septic arthritis caused by Bacteroides thetaiotaomicrom: A case report and review.

Authors:  D Brandariz-Núñez; J Gálvez-López
Journal:  Rev Esp Quimioter       Date:  2021-10-05       Impact factor: 1.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.